Understanding lymphangiogenesis: mechanisms and implications

Lymphangiogenesis is the biological process through which new lymphatic vessels are formed from pre-existing ones. This phenomenon is crucial for maintaining fluid homeostasis, facilitating immune cell trafficking, and supporting tissue repair. It plays a significant role in various physiological and pathological conditions, including inflammation, tumor metastasis, and cardiovascular diseases.

AnyGenes qPCR arrays enhance research in the lymphangiogenesis by providing accurate gene expression data related to lymphatic vessel formation. These tools enable researchers to identify key biomarkers associated with lymphangiogenesis, paving the way for targeted therapies for lymphatic disorders like lymphedema and certain cancers.

Discover our advanced qPCR arrays for Lymphangiogenesis research.

AMPK substrates act in specific subcellular locales to rewire metabolism.

Growth factor and cytokine signaling pathways in lymphangiogenesis. Growth factors derived from tumor cells, inflammatory cells, or other cell types activate their receptors on the surface of LECs and initiate various signaling cascades, leading to lymphatic vessel growth. Coordinately, these factors regulate cell migration, proliferation, and survival and vessel dilation and remodeling. Interactions between adjacent LECs via ANG/TIE2, DLL4/Notch1, and EFNB2/EPHB4 also contribute to the regulation of lymphangiogenic activity. Note that in contrast to ANG1, ANG2 is predominantly an autocrine ligand and that both angiopoietins bind with equal affinity to TIE2 and induce in trans ligand receptor complexes among ECs (103). Inhibitors that target the various involved molecules are indicated in red, and some of the key signaling consequences in blue.

Mechanisms of lymphangiogenesis

The process of lymphangiogenesis can be categorized into two main types.

Neo-lymphangiogenesis: This occurs during embryonic development when lymphatic endothelial cells (LECs) arise from progenitor cells.
Sprouting lymphangiogenesis: This involves the proliferation and migration of LECs from existing lymphatic vessels into the extracellular matrix (ECM) in response to specific stimuli

Key factors influencing the formation of new lymphatic vessels include:

Vascular Endothelial Growth Factors (VEGF): Particularly VEGF-C and VEGF-D, which promote LEC proliferation and migration.
Biochemical Signals: Various growth factors and cytokines that modulate the behavior of LECs.
Mechanical Cues: Interstitial fluid flow and shear stress that enhance LEC sprouting and vessel formation.

Role in health and diseases

The formation of new lymphatic vessels is vital for several physiological processes:

Fluid Balance: It helps in draining excess interstitial fluid, preventing edema.
Immune Function: By facilitating the transport of immune cells to lymph nodes, it enhances the immune response.
Tissue Repair and Wound Healing: Promotes healing by supplying nutrients and removing waste products.

In pathological contexts, dysregulation of lymphangiogenesis can contribute to conditions such as:

Cancer Metastasis: Tumors can exploit lymphatic pathways to spread to distant sites.
Cardiovascular Diseases: Impaired lymphatic function has been linked to conditions like atherosclerosis and myocardial infarction.

Lymphangiogenesis and cancer

Tumors often promote formation of new lymphatic vessels, allowing cancer cells to escape the primary tumor site and spread through the lymphatic system. This process not only facilitates metastasis but also alters the tumor microenvironment, impacting immune responses. Studies have shown that the formation of new lymphatic vessels often occurs in the draining lymph nodes before the arrival of metastatic cells, suggesting that tumors can create a pre-metastatic niche conducive to metastasis.

Therapeutic applications

Research into the formation of new lymphatic vessels has opened new avenues for therapeutic interventions. Targeting specific growth factors and signaling pathways may offer potential strategies for enhancing lymphatic function in conditions like lymphedema or inhibiting the formation of new lymphatic vessels in cancer to prevent metastasis. Moreover, advancing our understanding of lymphangiogenic processes could lead to novel treatments for inflammatory diseases and wound healing therapies.

Analyze your pathway data with AnyGenes® software

Scientific data is only as powerful as the analysis behind it.

AnyGenes® provides a dedicated data analysis tool specifically developed for SignArrays® pathway panels.

What does it allow you to do?

Automated ΔCq calculation
Normalization with selected housekeeping genes
Comparison of up to 10 experimental conditions
Generation of descriptive statistics
Publication-ready graphs
Exportable tables for manuscripts and presentations

Developed on Excel (compatible with 2007+), the software is user-friendly and requires no advanced bioinformatics skills.

Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file and send it at [email protected] to initiate your project.

Lymphangiogenesis biomarker list

You can check the biomarker list included in this pathway, see below:

Species : Homo sapiens (human)

Human signaling pathways

Signaling Pathways	Product ref	Informations
Lymphangiogenesis	LA1H1	Download biomarker list

Species : Mus musculus (mouse)

Mouse signaling pathways

Signaling Pathways	Product ref	Informations
Lymphangiogenesis	LA1M1	Download biomarker list

Species : Rattus norvegicus (rat)

Rat signaling pathways

Signaling Pathways	Product ref	Informations
Lymphangiogenesis	*******	Biomarker list in progress.

Species : Sus Scrofa (Pig)

Pig Lymphangiogenesis

Signaling Pathways	Product ref	Informations
Lymphangiogenesis	*******	Biomarker list in progress.

Looking for more answers? Visit our Help & FAQ section to find detailed informations about our products, services, and technical support.

Bibliography

1. Tronolone JJ, et al. Engineering Lymphangiogenesis-On-Chip: The Independent and Cooperative Regulation by Biochemical Factors, Gradients, and Interstitial Fluid Flow. Adv Biol (Weinh). (2024);8(4):e2400031.

2. Liu X, et al. Promoting Lymphangiogenesis and Lymphatic Growth and Remodeling to Treat Cardiovascular and Metabolic Diseases. Arterioscler Thromb Vasc Biol. (2023);43(1):e1-e10.

3. Cho Y, et al. Three-Dimensional In Vitro Lymphangiogenesis Model in Tumor Microenvironment. Front Bioeng Biotechnol. (2021)4:9:697657.

4. Zheng W, et al. Lymphangiogenic factors, mechanisms, and applications. J Clin Invest. (2014);124(3):878-87.

Need pricing information or distributor details?
For quotations, product information, or project discussions, please contact our team at [email protected].